AAD
  • Registration
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Topics
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Resources
  • Registration
Facebook iconInstagram iconTwitter icon
Mar 28, 2022

We know you love a good challenge

Check out our social media challenge.


Img 2619

Are you looking to win big while at the Annual Meeting? You’re in luck! There will be two exciting social media challenges at the 2022 AAD Annual Meeting for attendees to participate in.

Instagram Photo Challenge: Share a photo of yourself and/or colleagues while at the meeting with the hashtag #AAD2022challenge.

Twitter Pearl Challenge: Tweet your top pearls or key takeaways from your favorite sessions with the hashtag #AAD2022challenge.

For each challenge, one randomly selected participant will win free registration to either the 2022 AAD Innovation Academy in Vancouver, British Columbia, or the 2023 AAD Annual Meeting in New Orleans (winner’s choice).

Each photo shared on Instagram and every tweet that includes the hashtag will be considered a valid entry — and there is no limit to how many entries an attendee can submit. All entries must be submitted between 7 a.m. EST, March 25, and 11:59 p.m. EST, March 29. (AAD members only, U.S. or international.)

In the meantime, be sure to follow @AADmember on Twitter, Facebook, 
and Instagram to get the latest updates on Annual Meeting sessions, events, the exhibit hall, and more. Plus, see if you’re in one of the many photos that will be featured on all three social media accounts throughout the meeting!  

Visit AAD DermWorld Meeting News Central for more articles.

 

Instagram and Twitter Challenge Rules & Regulations

Official Rules & Regulations:

How to enter the #AAD2022challenge on Instagram (the “Contest”):

  • Post a photo with colleagues at the 2022 AAD Annual Meeting on Instagram between 7:30 a.m. (EST) on Friday, March 25 to 11:59 p.m. (EST) on Tuesday, March 29.
  • Include the hashtag #AAD2022challenge in each submission.

How to enter the #AAD2022challenge on Twitter (the “Contest”):

  • Tweet a key learning or clinical pearl from a session at the 2022 AAD Annual Meeting between 7:30 a.m. (EST) on Friday, March 25 to 11:59 p.m. (EST) on Tuesday, March 29.
  • Include the hashtag #AAD2022challenge in each submission.

Each submission will count as one (1) entry, with no limit to the number of entries per day per entrant.

Entries may not contain profanity, nudity, pornographic images, violent images, anti-competition messages, illegal material, material that violates the rights of third parties, or any other materials that is in violation of any federal, state, or local laws.

Entering the promotion constitutes permission for AAD to use your photo and caption in any manner it deems necessary or appropriate on its website, social media, print publications, or any other media without compensation and in perpetuity. By submitting any photos or videos containing the names or images of any third parties, you also represent and warrant that you have the consent of all such third parties to use their names and/or images, and you further agree to indemnify, defend, and hold AAD harmless from any third party claims or damages arising out of any breach of the foregoing warranty.

Prize: One (1) randomly selected winner will receive one (1) complimentary registration to either the 2022 AAD Innovation Academy in Vancouver, British Columbia or to the 2023 AAD Annual Meeting in New Orleans, Louisiana (winner’s choice). Complimentary registration is only valid for these meetings and is non-transferable to any other individual or AAD meeting. The odds of winning a prize depend upon the number of individuals who participate in the contest. Prize winners are responsible for any applicable federal, state and local taxes on their prize.

Prize Eligibility: No purchase necessary to participate or win. Open to registered attendees of the 2022 AAD Annual Meeting who are age 18 or older at the time of entry and are an AAD member in one of the following categories: Physician, Adjunct, Life, Honorary, Graduate Member, Resident, Medical Fellow in U.S. & Canadian AAD-approved programs, and International members. This does not include individuals registered for the 2022 Annual Meeting under the Day Pass registration category. Exhibitors may submit entries as long as they are not promoting their company, booth, or a product or brand. AAD employees and their immediate family as well as AAD officers and board members are not eligible for entry.

Winner Selection:  One (1) winner will be randomly chosen from each challenge (Instagram Photo Challenge and Twitter Pearl Challenge) among the total submissions from the previous five days by 11:59 p.m. on Tuesday, March 29. Potential winning entrants will be contacted through a private message on Instagram (Instagram Direct) or Twitter Direct Message. If a potential winning entrant does not respond to correspondence within 72 hours, the potential winning entrant will be disqualified, and a new winning entrant will be selected by random drawing.

Restrictions; Release of Liability; Additional Terms: This Contest is void where prohibited or restricted by law, and is subject to all federal, state, and local laws and regulations. Participation in the Contest constitutes entrant’s full and unconditional agreement to and acceptance of these Official Rules & Regulations. By participating, attendees confirm that they release Instagram and/or Twitter of responsibility and agree to Instagram’s and Twitter’s Terms of Use.

Neither AAD nor anyone involved in administering or providing prizes for the Contest will have liability for (A) technical malfunctions, including those arising from electronic, hardware, software, network, Internet or computer malfunctions, (B) any damages or losses of any kind caused by any acceptance, possession or use of the prize, or (C) inaccessibility or unavailability of AAD’s exhibitor floor in whole or in part for any reason.

By participating in the Contest, the winners agree that under no circumstances will AAD, its affiliates, and their officers, directors, employees, agents, or licensees (“Released Parties”) be liable for any form of damages arising out of their participation in the Contest, including but not limited to any injuries that winners or others may suffer while at the meeting venue, and each winner and his/her family and heirs further waive any rights to bring any claim against the Released Parties in any forum related to their participation in the Contest.

If for any reason this Contest is not capable of being conducted as planned due to infection by computer virus, bugs, tampering, unauthorized intervention, fraud, technical failures, acts of God, government regulations, or any other causes which, in the sole opinion of AAD, corrupt or affect the administration, security, fairness, integrity, or proper conduct of this Contest, AAD reserves the right to cancel, terminate, modify or suspend the Contest. This Contest is also void where prohibited by law, including in jurisdictions requiring registration, filing, trust account, or posting of a bond, or any other requirements or disclosures that are not expressly satisfied by these contest Rules and Regulations.

Interesting Stories
Residents and Young Physicians: Your Guide to the AAD Annual Meeting
Presented by Neutrogena
Residents and Young Physicians: Your Guide to the AAD Annual Meeting
Beyond the Scalp: Deciphering the Complexities of Alopecia Areata...
Presented by Pfizer Inc.
Beyond the Scalp: Deciphering the Complexities of Alopecia Areata...
Advancing Therapeutic Conversations
Presented by AbbVie
Advancing Therapeutic Conversations
Janssen-Sponsored Symposium
Presented by Janssen Biotech, Inc.
Janssen-Sponsored Symposium
Join Us to Learn More About SOTYKTU<sup>TM</sup> (deucravacitinib):
Presented by Bristol Myers Squibb
Join Us to Learn More About SOTYKTUTM (deucravacitinib):
Prurigo Nodularis and Atopic Dermatitis:
Presented by Sanofi and Regeneron Pharmaceuticals, Inc.
Prurigo Nodularis and Atopic Dermatitis:
What makes a biosimilar and an Interchangeable biosimilar different?
Presented by Boehringer Ingelheim
What makes a biosimilar and an Interchangeable biosimilar different?
More in AAD 2022 Annual Meeting
Aad Ia22 Welcome Guide Cover
2022 AAD Innovation Academy
Your Welcome Guide to Innovation Academy
Jul 13, 2022
AAD
Facebook iconInstagram iconTwitter icon
© Ascend Media All rights reserved. DermWorld Meeting News Central is a publication of the American Academy of Dermatology.